Skip to main navigation Skip to search Skip to main content

The IARC Monographs: Updated procedures for modern and transparent evidence synthesis in cancer hazard identification

  • Jonathan M Samet
  • , Weihsueh A Chiu
  • , Vincent Cogliano
  • , Jennifer Jinot
  • , David Kriebel
  • , Ruth M Lunn
  • , Frederick A Beland
  • , Lisa Bero
  • , Patience Browne
  • , Lin Fritschi
  • , Jun Kanno
  • , Dirk W Lachenmeier
  • , Qing Lan
  • , Gérard Lasfargues
  • , Frank Le Curieux
  • , Susan Peters
  • , Pamela Shubat
  • , Hideko Sone
  • , Mary C White
  • , Jon Williamson
  • Marianna Yakubovskaya, Jack Siemiatycki, Paul A White, Kathryn Z Guyton, Mary K Schubauer-Berigan, Amy L Hall, Yann Grosse, Véronique Bouvard, Lamia Benbrahim-Tallaa, Fatiha El Ghissassi, Béatrice Lauby-Secretan, Bruce Armstrong, Rodolfo Saracci, Jiri Zavadil, Kurt Straif, Christopher P Wild
    • Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, USA.
    • Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA.
    • US Environmental Protection Agency, USA.
    • US Environmental Protection Agency, USA [retired].
    • University of Massachusetts Lowell, USA.
    • National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, USA.
    • Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR, USA.
    • University of Sydney
    • Organisation for Economic Co-operation and Development (OECD), France.
    • Curtin University of Technology
    • Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Japan.
    • Chemical and Veterinary Investigation Agency Karlsruhe, Germany.
    • National Cancer Institute United States
    • French Agency for Food, Environmental and Occupational Health & Safety (ANSES), France.
    • European Chemicals Agency (ECHA), Finland.
    • Environmental Health Division, Minnesota Department of Health, USA [retired].
    • National Institute for Environmental Studies [retired], Yokohama University of Pharmacy, Japan.
    • Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, United States of America (USA).
    • University of Kent, United Kingdom.
    • Ministry of Health, Russian Federation.
    • McGill University
    • Correctional Service of Canada, Central Ontario District (Parole), Psychology Department, Toronto, Ont.; McMaster — Centre for Addiction and Mental Health; Law and Mental Health Program, Toronto, Ont., Canada
    • Epigenetics Group, International Agency for Research on Cancer, Lyon, France.
    • International Agency for Research on Cancer, Lyon, France [Senior Visiting Scientist].
    • International Agency for Research on Cancer, Lyon, France [retired from IARC 11/30/18].
    • International Agency for Research on Cancer, Lyon, France [retired from IARC 12/31/18].

    Research output: Contribution to journalArticleAcademicpeer-review

    Abstract

    The Monographs produced by the International Agency for Research on Cancer (IARC) apply rigorous procedures for the scientific review and evaluation of carcinogenic hazards by independent experts. The Preamble to the IARC Monographs, which outlines these procedures, was updated in 2019, following recommendations of a 2018 expert Advisory Group. This article presents the key features of the updated Preamble, a major milestone that will enable IARC to take advantage of recent scientific and procedural advances made during the 12 years since the last Preamble amendments. The updated Preamble formalizes important developments already being pioneered in the Monographs Programme. These developments were taken forward in a clarified and strengthened process for identifying, reviewing, evaluating and integrating evidence to identify causes of human cancer. The advancements adopted include strengthening of systematic review methodologies; greater emphasis on mechanistic evidence, based on key characteristics of carcinogens; greater consideration of quality and informativeness in the critical evaluation of epidemiological studies, including their exposure assessment methods; improved harmonization of evaluation criteria for the different evidence streams; and a single-step process of integrating evidence on cancer in humans, cancer in experimental animals and mechanisms for reaching overall evaluations. In all, the updated Preamble underpins a stronger and more transparent method for the identification of carcinogenic hazards, the essential first step in cancer prevention.

    Original languageEnglish
    Pages (from-to)30-37
    JournalJournal of the National Cancer Institute
    Volume112
    Issue number1
    DOIs
    Publication statusPublished - 9 Sept 2019

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'The IARC Monographs: Updated procedures for modern and transparent evidence synthesis in cancer hazard identification'. Together they form a unique fingerprint.

    Cite this